CHIMERIC LEPTIN FUSED TO IMMUNOGLOBULIN DOMAIN AND USE

(19)

(11)

EP 0 832 219 A2

(12)

(43)	Date of publication:
	01.04.1998 Bulletin 1998/14

(21)	Application number: 96917584.0

(22)	Date of filing: 11.06.1996

(51)

International Patent Classification (IPC):

C12N 15/ 09^{( . )}
A61P 3/ 04^{( . )}
C07K 14/ 575^{( . )}
C07K 19/ 00^{( . )}
C12N 1/ 19^{( . )}
C12N 5/ 10^{( . )}
C12P 21/ 02^{( . )}

A61K 38/ 00^{( . )}
C07K 14/ 47^{( . )}
C07K 16/ 00^{( . )}
C12N 1/ 15^{( . )}
C12N 1/ 21^{( . )}
C12N 15/ 12^{( . )}

(86)	International application number:
	PCT/GB1996/001388

(87)	International publication number:
	WO 1997/000319 (03.01.1997 Gazette 1997/02)

(84)	Designated Contracting States:
	BE CH DE DK ES FR GB IT LI NL

(30)

Priority:

13.06.1995 GB 19950011935

(71)	Applicant: SMITHKLINE BEECHAM PLC
	Brentford, Middlesex TW8 9EP (GB)

(72)	Inventors:
	BROWNE, Michael Joseph, SmithKline Beecham Pharm. Harlow, Essex CM19 5AD (GB) CHAPMAN, Conrad Gerald, SmithKline Beecham Pharm. Harlow, Essex CM19 5AD (GB) CLINKENBEARD, Helen Elizabeth, SmithKline Beecham Harlow, Essex CM19 5AD (GB) ROBINSON, Jeffrey Hugh, SmithKline Beecham Pharm. Harlow, Essex CM19 5AD (GB)

(74)	Representative: Rutter, Keith, Dr., et al
	SmithKline Beecham plc Corporate Intellectual Property, Two New Horizons Court Brentford, Middlesex TW8 9EP Brentford, Middlesex TW8 9EP (GB)

(54)	CHIMERIC LEPTIN FUSED TO IMMUNOGLOBULIN DOMAIN AND USE